Pei Wenhui, Chen Zhefan Stephen, Chan Ho Yin Edwin, Zheng Liming, Liang Chen, Huang Caoxing
Guangxi Key Laboratory of Clean Pulp & Papermaking and Pollution Control, Guangxi University, Nanning, China.
Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Department of Bioengineering, Nanjing Forestry University, Nanjing, China.
Front Bioeng Biotechnol. 2020 Sep 25;8:573991. doi: 10.3389/fbioe.2020.573991. eCollection 2020.
Lignin-carbohydrate complex (LCC) is the biological macromolecule that has been demonstrated to exert multiple biological functions, including antioxidant, anti-inflammation and anti-tumorigenesis, which support its broad application in the bioengineering field. However, it remains elusive the involvements of LCC in human neurological disorders, especially those with the overproduction of reactive oxygen species (ROS), such as spinocerebellar ataxias (SCAs). In this study, we found a previously undetermined anti-protein aggregation activity of LCC. Initially, two individual LCC preparations and carbohydrate-free lignin were isolated from the water-extracted waste residues of () tender leaves. The chemical compositional analysis revealed that lignin (61.5%) is the predominant constituent in the lignin-rich LCC (LCC-L-CR), whereas the carbohydrate-rich LCC (LCC-C-CR) is mainly composed of carbohydrate (60.9%) with the xylan as the major constituent (42.1%). The NMR structural characterization showed that LCC-L-CR preparation is enriched in benzyl ether linkage, while phenyl glycoside is the predominant type of linkage in LCC-C-CR. Both LCC and lignin preparations showed antioxidant activities as exemplified by their abilities to scavenge free radicals in cultured mammalian cells and ROS in zebrafish. We further demonstrated a pronounced capability of LCC-L-CR in inhibiting the aggregation of expanded Ataxin-3, disease protein of SCA type 3, in human neuronal cells. Taken together, our study highlights the antioxidant and novel anti-protein aggregation activities of the tender leaves-derived LCC.
木质素-碳水化合物复合物(LCC)是一种生物大分子,已被证明具有多种生物学功能,包括抗氧化、抗炎和抗肿瘤作用,这支持了其在生物工程领域的广泛应用。然而,LCC在人类神经疾病中的作用,尤其是在活性氧(ROS)过度产生的疾病中的作用,如脊髓小脑共济失调(SCA),仍不清楚。在本研究中,我们发现了LCC一种先前未确定的抗蛋白质聚集活性。最初,从()嫩叶的水提取废渣中分离出两种单独的LCC制剂和无碳水化合物木质素。化学组成分析表明,木质素(61.5%)是富含木质素的LCC(LCC-L-CR)中的主要成分,而富含碳水化合物的LCC(LCC-C-CR)主要由碳水化合物(60.9%)组成,其中木聚糖是主要成分(42.1%)。核磁共振结构表征表明,LCC-L-CR制剂富含苄基醚键,而苯基糖苷是LCC-C-CR中主要的键型。LCC和木质素制剂都表现出抗氧化活性,例如它们在培养的哺乳动物细胞中清除自由基和在斑马鱼中清除ROS的能力。我们进一步证明了LCC-L-CR在抑制人神经细胞中扩展的Ataxin-3(SCA3型疾病蛋白)聚集方面具有显著能力。综上所述,我们的研究突出了嫩叶来源的LCC的抗氧化和新型抗蛋白质聚集活性。